ACUR Financial Facts

Income (loss) from operations: -2.07M
Total operating expenses: 2.29M
See Full Income Statement

Cash and cash equivalents: 4.27M
Total current liabilities: 4.2M
See Full Balance Sheet

Acura Pharmaceuticals, Inc. (ACUR) Earnings

  |   Expand Research on ACUR
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -73.7% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -5.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/18/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
11/11/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
8/26/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
8/20/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
5/27/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
5/21/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
2/28/24 Q423 N/AN/A N/A N/AN/A N/A N/A N/A
11/13/23 Q323 N/AN/A N/A N/AN/A N/A N/A N/A